M. R. J. Gibbs

M. R. J. Gibbs

Auto-generated profile, based on publicly available information

M. R. J. Gibbs

Clinical Development, Vaccines & Immunotherapies, AstraZeneca, Cambridge, UK

Research Focus & Metrics

Academic Career Length

35Years (1992-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 1993 in IEEE Transactions on Magnetics
Verified
Journal Article
Closed access
CGC.D. Graham
C.D. Graham
MGM.R.J. Gibbs
M.R.J. Gibbs


29 July 2023 in Journal of Infection and Chemotherapy
Verified
Journal Article
Open access
HOHiroshi Okada
Hiroshi Okada
KIKensuke Ishikawa
Kensuke Ishikawa
YIYohji Itoh
Yohji Itoh
YNYoshinori Noda
Yoshinori Noda
TETakashi Eto
Takashi Eto
EJEva Johnsson
Eva Johnsson
The aim of this study was to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of AZD7442 (tixagevimab/cilgavimab) in healthy Japanese adults. In this randomized, double-blind, placebo-controlled, phase 1 study, AZD7442 was administered intramuscularly (300 or 600 mg) or intravenously (300 or 1000 mg) to healthy Japanese adults. Primary endpoints were safety, tolerability, and pharmacokinetics. Anti-drug antibodies and neutralizing antibody activities were secondary endpoints. A total of 40 participants were randomized to receive AZD7442 (n = 30) or placebo (n = 10). Adverse events (AEs) occurred in 12 (40%) and 3 (30%) participants, respectively; there were no deaths, serious AEs, or AEs leading to study withdrawal. Tixagevimab and cilgavimab had mean half-lives of 82.1-95.9 and 77.9-92.0 days, respectively, which were generally similar regardless of administration route. SARS-CoV-2-neutralizing antibody titers were >4-fold higher than baseline levels from Day 8 to Day 211 in participants receiving AZD7442. AZD7442 was well tolerated in healthy Japanese adults, with predictable pharmacokinetics and an extended half-life, consistent with previous studies. gov, NCT04896541.

1 June 1992 in Journal of Magnetism and Magnetic Materials
Verified
Journal Article
Closed access
ICI.T. Collier
I.T. Collier
MGM.R.J. Gibbs
M.R.J. Gibbs
NSN. Seddon
N. Seddon

1 December 1994 in Hyperfine Interactions
Verified
Journal Article
Closed access
PDF file
Jianzhong JiangJianzhong Jiang
Jianzhong Jiang
QPQuentin Pankhurst
Quentin Pankhurst
MGM. R. J. Gibbs
M. R. J. Gibbs